Rheumatic And Autoimmune Diseases

The NIH has launched a clinical trial to examine antibody responses to a COVID-19 vaccine booster dose in patients with autoimmune disease who failed to respond to the initial vaccine regimen.

The presence of mature red blood cells that still contain mitochondria is associated with higher systemic lupus erythematosus disease activity, according to data published in Cell.

Persistent low-to-moderate thrombocytopenia can identify patients with antiphospholipid syndrome who are at high risk for thrombosis, and is linked to poor long-term survival, according to data published in Rheumatology.

Despite the ongoing setbacks presented by the COVID-19 pandemic, the Congress of Clinical Rheumatology – West will follow its East counterpart just a month later, offering a wholly new selection of “charismatic and engaging” speakers.

Adverse events were rare and mild in patients with rheumatic diseases who received a COVID-19 vaccine, according to data from the EULAR–COVID-19 Registry presented at the EULAR 2021 Congress.

Adverse events were rare and mild in patients with rheumatic diseases who received a COVID-19 vaccine, according to data from the EULAR–COVID-19 Registry presented at the EULAR 2021 Congress.

The severity and cost of work-related musculoskeletal disorders among Ohio construction workers from 2007 to 2017 increased with age, peaking in those aged 55 to 64 years, according to data published in Morbidity and Mortality Weekly Report.

Elevating the rheumatology’s profile to policymakers, medical students and patients through advocacy and education is critical for the specialty’s future, according to EULAR President Annamaria Iagnocco, MD.